206
Participants
Start Date
April 4, 2020
Primary Completion Date
January 31, 2022
Study Completion Date
May 1, 2023
Camostat Mesilate
Serine protease inhibitor that blocks TMPRSS-2 mediated cell entry of SARS-CoV-2
Placebo oral tablet
Placebo
Bispebjerg hospital, Copenhagen
Northzealands hospital - Hillerød, Hillerød
Dept. of Infectious Diseases, Odense University Hospital, Odense
Herning Regional Hospital, Herning
Department for Infectious Diseases, Aarhus University Hospital, Aarhus N
Silkeborg Hospital, Silkeborg
Horsens Regional Hospital, Horsens
Randers Regional Hospital, Randers
Region Hospital North Jutland, Hjørring
Department of Infectious Diseases, Aalborg
Örebro Hsopital, Örebro
University of Aarhus
OTHER